Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine C2 vs tacrolimus for hepatitis C recurrence in de novo liver transplant recipients
2005-002266-10Phase 4Active
- Sponsor
- Dr. Evaristo Varo Pérez
- Start
- Sep 2005
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of cyclosporine and tacrolimus in hepatitis C virus infection and hepatic disease (2 arms), sponsored by Dr. Evaristo Varo Pérez. Primary endpoint: Histologic severity of recurrent hepatitis C at 12 months. Started Sep 2005; status: active.
02
Drugs
cyclosporinetacrolimus
03
Conditions
hepatitis C virus infectionhepatic disease
Beyond the preview
Go deeper on 2005-002266-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002266-10.